• Presented at International Society for Pharmacoeconomics and Outcomes Research  (ISPOR) (2021)

  • Collaborators: GEM Resopso, Université Sorbonne Paris Nord

  • Authors: Halioua B, Zetlaoui J, Astruc A, Harrizi M, Bombezin–Domino A, Radoszycki L

Patients with Chronic Medical Conditions (CMC) require regular access to healthcare professionals and have to take long-term treatments. The COVID-19 pandemic may affect their clinical outcomes

Objective: The present study aims to assess the first post-lockdown impact of the COVID-19 outbreak on CMC patients living in the United States.